|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
|
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash and cash equivalents (Note 3) | ||||||||
| Investments (Note 4) | ||||||||
| Trade receivables and other assets (Note 5) | ||||||||
| Loan receivable | ||||||||
| Total current assets | ||||||||
| Restricted cash | ||||||||
| Strategic investments | ||||||||
| Investment in SLM California (Note 6) | ||||||||
| Royalty and other property interests (Note 7) | ||||||||
| Property and equipment | ||||||||
| Deferred charges | ||||||||
| Deferred income tax asset | ||||||||
| Total non-current assets | ||||||||
| Total Assets | ||||||||
| Liabilities | ||||||||
| Current liabilities [abstract] | ||||||||
| Accounts payable and accrued liabilities | ||||||||
| Advances from joint venture partners (Note 8) | ||||||||
| Derivative liabilities (Note 9) | ||||||||
| Loan payable (Note 10) | ||||||||
| Total current liabilities | ||||||||
| Non-current liabilities [abstract] | ||||||||
| Loan payable (Note 10) | ||||||||
| Deferred income tax liability (Note 11) | ||||||||
| Total non-current liabilities | ||||||||
| Total Liabilities | ||||||||
| Shareholders' Equity | ||||||||
| Capital stock (Note 12) | ||||||||
| Reserves | ||||||||
| Deficit | ||||||||
| Total Shareholders' Equity | ||||||||
| Total Liabilities and Shareholders' Equity | ||||||||
Loading...
